Pathophysiology of migraine: a disorder of sensory processing

Cited by (1,001)

Items 201–300 of 1,001

1. Implications of Transient Receptor Potential Cation Channels in Migraine Pathophysiology
   Mamoru Shibata, Chunhua Tang · 2020 · Neuroscience Bulletin
2. Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
   Luigi Francesco Iannone, Francesco De Cesaris, Anita Ferrari, Silvia Benemei, Davide Fattori, Alberto Chiarugi · 2022 · Cephalalgia
3. The role of pain modulation pathway and related brain regions in pain
   Dandan Yao, Yeru Chen, Gang Chen · 2023 · Reviews in the Neurosciences
4. Migraine: Advances in the Pathogenesis and Treatment
   Horia Pleș, Ioan Alexandru Florian, Teodora Larisa Timiș, Răzvan-Adrian Covache-Busuioc, Luca-Andrei Glavan, David-Ioan Dumitrascu, Andrei Adrian Popa, Andrei Bordeianu, Alexandru Vlad Ciurea · 2023 · Neurology International
5. Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat
   Ram Kandasamy, Cole T. Dawson, Rebecca M. Craft, Michael M. Morgan · 2017 · European Journal of Pharmacology
6. Evidence of an increased neuronal activation-to-resting glucose uptake ratio in the visual cortex of migraine patients: a study comparing 18FDG-PET and visual evoked potentials
   Marco Lisicki Martinez, Kevin D’Ostilio, Gianluca Coppola, Félix Scholtes, Alain Maertens de Noordhout, Vincenzo Parisi, Jean E. Schoenen, Delphine Magis · 2018 · The Journal of Headache and Pain
7. Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials
   Stephen David Silberstein, Peter McAllister, Xiaoping Ning, Nicola Faulhaber, Nicole Lang, Paul P. Yeung, Jimmy Schiemann, Ernesto Aycardi, Joshua M. Cohen, Lindsay Janka et al. · 2019 · Headache The Journal of Head and Face Pain
8. Genetic mouse models of migraine
   Daniela Pietrobon, K. C. Brennan · 2019 · The Journal of Headache and Pain
9. Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems?
   Nazia Karsan, Peter James Goadsby · 2021 · Frontiers in Human Neuroscience
10. Dietary magnesium and migraine in adults: A cross‐sectional analysis of the National Health and Nutrition Examination Survey 2001–2004
    Margaret Slavin, Huilun Li, Manisha Khatri, Cara Lea Frankenfeld · 2021 · Headache The Journal of Head and Face Pain
11. Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine
    Rosaria Greco, Chiara Demartini, Miriam Francavilla, Anna Maria Zanaboni, Cristina Tassorelli · 2022 · Cells
12. TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine
    Eleonóra Spekker, Tamás Körtési, László Vécsei · 2022 · International Journal of Molecular Sciences
13. A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine
    Robert S. Croop, Gary Berman, David Kudrow, Kathleen Mullin, Alexandra Thiry, Meghan Lovegren, Gilbert J L'Italien, Richard B. Lipton · 2024 · Cephalalgia
14. Flunarizine in migraine‐related headache prevention: results from 200 patients treated in the UK
    Nazia Karsan, David Palethorpe, Wanakorn Rattanawong, Juana Marin, Ria Bhola, Peter James Goadsby · 2018 · European Journal of Neurology
15. Technologies to Study Action Potential Propagation With a Focus on HD-MEAs
    Vishalini Emmenegger, Marie Engelene J. Obien, Felix Franke, Andreas R. Hierlemann · 2019 · Frontiers in Cellular Neuroscience
16. Disrupted functional connectivity between sub-regions in the sensorimotor areas and cortex in migraine without aura
    Zhaoxia Qin, Jingjing Su, Xinwei He, Shiyu Ban, Qian Zhu, Yangyang Cui, Jilei Zhang, Yue Hua Hu, Yi-Sheng Liu, Rong Zhao et al. · 2020 · The Journal of Headache and Pain
17. Prolactin and oxytocin: potential targets for migraine treatment
    Anna K. Szewczyk, Samiye Ulutas, Tülin Aktürk, Linda Al‐Hassany, Corinna Börner, Federica Cernigliaro, Michalis Kodounis, Salvatore Lo Cascio, David Mikolajek, Dilara Onan et al. · 2023 · The Journal of Headache and Pain
18. Aromatherapy for the brain: Lavender's healing effect on epilepsy, depression, anxiety, migraine, and Alzheimer's disease: A review article
    Nazanin Hatami Bavarsad, Shokufeh Bagheri, Masoumeh Kourosh‐Arami, Alireza Komaki‬ · 2023 · Heliyon
19. Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics
    Kofi Frimpong-Manson, Yuma T. Ortiz, Lance Richard McMahon, Jenny L. Wilkerson · 2024 · Frontiers in Molecular Neuroscience
20. Extensor/flexor ratio of neck muscle strength and electromyographic activity of individuals with migraine: a cross-sectional study
    Mariana Tedeschi Benatto, Lidiane Lima Florêncio, Marcela Mendes Bragatto, Samuel Straceri Lodovichi, Fabíola Dach, Débora Bevilaqua‐Grossi · 2019 · European Spine Journal
21. FAAH inhibition as a preventive treatment for migraine: A pre-clinical study
    Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, Elena Tumelero, Angelo M. Reggiani, Alessandra Misto, Daniele Piomelli, Cristina Tassorelli · 2019 · Neurobiology of Disease
22. Vitamin D serum levels in patients with migraine: A meta-analysis
    Ioannis Liampas, Vasileios Siokas, Alexandros G. Brotis, Efthimios Dardiotis · 2020 · Revue Neurologique
23. Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects
    Jason Charles Ray, Mahima Kapoor, Richard James Stark, Shuu‐Jiun Wang, Lars Bendtsen, Manjit Singh Matharu, Elspeth Jane Hutton · 2021 · Journal of Neurology Neurosurgery & Psychiatry
24. Headache in people with epilepsy
    Prisca Rachel Bauer, Else A. Tolner, Mark Robert Keezer, Michel Dominique Ferrari, Josemir W. A. S. Sander · 2021 · Nature Reviews Neurology
25. Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults
    Peter James Goadsby, Stewart J. Tepper, Paul Brent Watkins, Girma Moges Ayele, Rosa Miceli, Matthew James Butler, Lawrence Severt, Michelle Finnegan, Armin Szegedi, Joel M. Trugman et al. · 2019 · Cephalalgia
26. Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model
    Ruimin Tian, Yun Zhang, Qi Pan, Yunfeng Wang, Qianwen Wen, Xiaoping Fan, Guangcheng Qin, Dunke Zhang, Lixue Chen, Yixin Zhang et al. · 2022 · The Journal of Headache and Pain
27. Phytomedicines in the Treatment of Migraine
    Thilinie Rajapakse, William Jeptha Davenport · 2019 · CNS Drugs
28. Redox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions
    Patrizia Ferroni, Piero Barbanti, David Della‐Morte, Raffaele Palmirotta, Emilio Jirillo, Fiorella Guadagni · 2017 · Antioxidants and Redox Signaling
29. Alterations in Functional Connectivity During Different Phases of the Triggered Migraine Attack
    Nazia Karsan, Pyari R Bose, Owen O’Daly, Fernando O. Zelaya, Peter James Goadsby · 2020 · Headache The Journal of Head and Face Pain
30. Exploring alterations in sensory pathways in migraine
    Noemi Meylakh, Luke A. Henderson · 2022 · The Journal of Headache and Pain
31. Sex differences in migraine attack characteristics: A longitudinal E‐diary study
    Iris E. Verhagen, Britt W. H. van der Arend, Daphne S. van Casteren, Saskia le Cessie, Antoinette MaassenVanDenBrink, Gisela Marie Terwindt · 2023 · Headache The Journal of Head and Face Pain
32. Initiation of spreading depression by synaptic and network hyperactivity: Insights into trigger mechanisms of migraine aura
    Lyudmila V. Vinogradova · 2017 · Cephalalgia
33. Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers
    J. N. J. M. De Hoon, Anne Van Hecken, Corinne Vandermeulen, Marissa Herbots, Yumi Kubo, Ed Lee, Osa Eisele, Gabriel A. Vargas, Kristin Gabriel · 2018 · Cephalalgia
34. Gain of Function for the SCN1A/hNav1.1-L1670W Mutation Responsible for Familial Hemiplegic Migraine
    Sandra Dhifallah, Eric Lancaster, Shana L. Merrill, Nathalie Leroudier, Massimo Mantegazza, Sandrine Cestèle · 2018 · Frontiers in Molecular Neuroscience
35. Pediatric Migraine
    Kaitlin A. Greene, Samantha Lee Irwin, Amy A. Gelfand · 2019 · Neurologic Clinics
36. GABA and glutamate in pediatric migraine
    Tiffany Bell, Mehak Stokoe, Akashroop Khaira, Megan Webb, Melanie E. Noel, Farnaz Amoozegar, Ashley D. Harris · 2020 · Pain
37. Glia and Orofacial Pain: Progress and Future Directions
    Yi Ye, Elizabeth Salvo, Marcela Romero‐Reyes, Simon Akerman, Emi Shimizu, Yoshifumi Kobayashi, Benoit Michot, Jennifer Lynn Gibbs · 2021 · International Journal of Molecular Sciences
38. Pre-treatment non-ictal cephalic allodynia identifies responders to prophylactic treatment of chronic and episodic migraine patients with galcanezumab: A prospective quantitative sensory testing study (NCT04271202)
    Sait Ashina, Agustin Melo‐Carrillo, Edina Szabó, David Borsook, Rami Burstein · 2023 · Cephalalgia
39. Energy metabolism disturbance in migraine: From a mitochondrial point of view
    Yi‐Cheng Wang, Yongli Wang, Guang-Xin Yue, Yonglie Zhao · 2023 · Frontiers in Physiology
40. Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine
    Håkan Ashina, Rune Häckert Christensen, Debbie L. Hay, Amynah A. A. Pradhan, Jan Hoffmann, Dóra Reglődi, Andrew F. Russo, Messoud Ashina · 2024 · Nature Reviews Neurology
41. Herbal treatments for migraine: A systematic review of randomised‐controlled studies
    Adrian L. Lopresti, Stephen James Smith, Peter D. Drummond · 2020 · Phytotherapy Research
42. Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID-19 recovered individuals: A systematic review and meta-analysis
    Jonny Karunia Fajar, Muhammad Ilmawan, Sukamto Salang Mamada, Endang Mutiawati, Milda Husnah, Hanifah Yusuf, Firzan Nainu, Salin Sirinam, Synat Keam, Youdiil Ophinni et al. · 2021 · Narra J
43. Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study
    Patricia Pozo‐Rosich, Holland C. Detke, Shufang Wang, David Doležil, Lily Q. Li, Sheena K. Aurora, Uwe Reuter · 2022 · Current Medical Research and Opinion
44. Molecular Mechanisms of Migraine: Nitric Oxide Synthase and Neuropeptides
    Nazia Karsan, Helin Gosalia, Peter James Goadsby · 2023 · International Journal of Molecular Sciences
45. Neuroimaging in the pre-ictal or premonitory phase of migraine: a narrative review
    Nazia Karsan, Peter James Goadsby · 2023 · The Journal of Headache and Pain
46. Genetics of migraine: complexity, implications, and potential clinical applications.
    H. Sutherland, Bronwyn Jenkins, L. Griffiths · 2024 · Lancet Neurology
47. The Trigeminal Sensory System and Orofacial Pain
    Hyung Kyu Kim, Ki-Myung Chung, Juping Xing, Hee Young Kim, D H Youn · 2024 · International Journal of Molecular Sciences
48. Susceptibility of the cerebral cortex to spreading depolarization in neurological disease states: The impact of aging
    Péter Hertelendy, Dániel Péter Varga, Ákos Menyhárt, Ferenc Bari, Eszter Farkas · 2018 · Neurochemistry International
49. Novel hypotheses emerging from GWAS in migraine?
    Arn M. J. M. van den Maagdenberg, Dale R. Nyholt, Verneri Anttila · 2019 · The Journal of Headache and Pain
50. PACAP and Other Neuropeptide Targets Link Chronic Migraine and Opioid-induced Hyperalgesia in Mouse Models*
    Krishna D. B. Anapindi, Ning Yang, Elena V. Romanova, Stanislav S. Rubakhin, Alycia F Tipton, Isaac J. Dripps, Zoie C. Sheets, Jonathan V. Sweedler, Amynah A. A. Pradhan · 2019 · Molecular & Cellular Proteomics
51. Altered resting‐state functional connectivity between subregions in the thalamus and cortex in migraine without aura
    Z. X. Qin, J. J. Su, Xingwei He, Qing Zhu, Yue Cui, Jiayan Zhang, M. X. Wang, T. T. Gao, Weijun Tang, Yue Hu et al. · 2020 · European Journal of Neurology
52. ACOG Clinical Practice Guideline No. 3: Headaches in Pregnancy and Postpartum
    2022 · Obstetrics and Gynecology
53. Real-World experience of interictal burden and treatment in migraine: a qualitative interview study
    Siu Hing Lo, Katy Gallop, Timothy R. Smith, Lauren C. Powell, Karissa Johnston, Lena Hubig, Emma Williams, Vladimir Coric, Linda A. Harris, Gilbert J L'Italien et al. · 2022 · The Journal of Headache and Pain
54. The Epigenetics of Migraine
    Farzin Zobdeh, Иван Иванович Еременко, Mikail A. Akan, Vadim V. Tarasov, Vladimir N. Chubarev, Helgi B. Schiöth, Jessica Mwinyi · 2023 · International Journal of Molecular Sciences
55. Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
    Edoardo Caronna, Victor José Gallardo, Gabriella Egeo, Manuel Millán Vázquez, Candela Nieves-Castellanos, Javier A. Membrilla, Gloria Vaghi, Joana Rodríguez-Montolio, Neus Fabregat Fabra, Francisco Sánchez-Caballero et al. · 2024 · Journal of Neurology Neurosurgery & Psychiatry
56. Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries
    Lena Ohlsson, Erik Kronvall, Jennifer Stratton, Lars IH Edvinsson · 2018 · The Journal of Headache and Pain
57. The Effects of Chronic Stress on Migraine Relevant Phenotypes in Male Mice
    Dan Kaufmann, K. C. Brennan · 2018 · Frontiers in Cellular Neuroscience
58. An Integrative Model Accounting for the Symptom Cluster Triggered After an Acoustic Shock
    Noreña, Arnaud J., Fournier, Philippe, Londero, Alain, Ponsot, Damien, Charpentier, Nicolas · 2018 · Trends in Hearing
59. Effects of Anti-Calcitonin Gene-Related Peptide for Migraines: A Systematic Review with Meta-Analysis of Randomized Clinical Trials
    I‐Hsin Huang, Po‐Chien Wu, En-Yuan Lin, Chien‐Yu Chen, Yi‐No Kang · 2019 · International Journal of Molecular Sciences
60. Alterations in Regional Homogeneity Assessed by fMRI in Patients with Migraine Without Aura
    Can Chen, Manyun Yan, Yang Yu, Jun Ke, Chunyang Xu, Xiaoning Guo, Haifeng Lu, Ximing Wang, Lan Hu, Jingwen Wang et al. · 2019 · Journal of Medical Systems
61. Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment
    Parisa Gazerani · 2019 · Molecular Diagnosis & Therapy
62. Interictal amylin levels in chronic migraine patients: A case-control study
    Pablo Irimia, Iván Martínez-Valbuena, Ane Mínguez‐Olaondo, Clara Domínguez‐Vivero, Juan Antonio Sánchez-Arias, Eduardo Martínez‐Vila, M. R. Luquín, Rogelio Leira · 2020 · Cephalalgia
63. Single‐Dose Pharmacokinetics and Safety of Atogepant in Adults With Hepatic Impairment: Results From an Open‐Label, Phase 1 Trial
    Ramesh Boinpally, Abhijeet S. Jakate, Matthew James Butler, Lisa Borbridge, Antonia P. Periclou · 2021 · Clinical Pharmacology in Drug Development
64. Patient‐identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient‐centered outcome
    Richard B. Lipton, David W. Dodick, Jessica Ailani, Lora McGill, Joe Hirman, Roger K. Cady · 2021 · Headache The Journal of Head and Face Pain
65. The Interplay Between Neuroinfections, the Immune System and Neurological Disorders: A Focus on Africa
    Leonard Ngarka, Joseph Nelson Siewe Fodjo, Esraa Aly, Willias Masocha, Alfred Kongnyu NJAMNSHI · 2022 · Frontiers in Immunology
66. Epigenetic Connection of the Calcitonin Gene-Related Peptide and Its Potential in Migraine
    Michał Fila, Anna Sobczuk, Elżbieta Pawłowska, Janusz Błasiak · 2022 · International Journal of Molecular Sciences
67. Cerebral blood flow alterations in migraine patients with and without aura: An arterial spin labeling study
    Tong Fu, Lindong Liu, Xiaobin Huang, Di Zhang, Yujia Gao, Xindao Yin, Hai Lin, Yongming Dai, Xinying Wu · 2022 · The Journal of Headache and Pain
68. Efficacy and safety of anti-calcitonin gene-related peptide monoclonal antibodies for treatment of chronic migraine: A systematic review and network meta-analysis
    Prashant Soni, Evanka Chawla · 2021 · Clinical Neurology and Neurosurgery
69. Visual Snow Syndrome as a Network Disorder: A Systematic Review
    Antonia Nicole Klein, Christoph Josef Schankin · 2021 · Frontiers in Neurology
70. Migraine-relevant sex-dependent activation of mouse meningeal afferents by TRPM3 agonists
    Georgii Krivoshein, Else A. Tolner, AMJM van den Maagdenberg, Rashid A. Giniatullin · 2022 · The Journal of Headache and Pain
71. The modulation effects of repeated transcutaneous auricular vagus nerve stimulation on the functional connectivity of key brainstem regions along the vagus nerve pathway in migraine patients
    Yiting Huang, Yue Zhang, Sierra Hodges, Hui Li, Zhaoxian Yan, Xian Liu, Xiaoyan Hou, Weicui Chen, Thalia Celeste Chai‐Zhang, Jian Kong et al. · 2023 · Frontiers in Molecular Neuroscience
72. Pharmacological Management of Orofacial Pain
    Marcela Romero‐Reyes, Sherwin Arman, Antonia Teruel, Satish Kumar, James M. Hawkins, Simon Akerman · 2023 · Drugs
73. Inhibitory G i/O -coupled receptors in somatosensory neurons: Potential therapeutic targets for novel analgesics
    Yevgen K. Yudin, Tibor Rohács · 2018 · Molecular Pain
74. Dynamic functional connectivity of the migraine brain: a resting-state functional magnetic resonance imaging study
    Mi Ji Lee, Bo‐yong Park, Soohyun Cho, Hyunjin Park, Sungtae Kim, Chin‐Sang Chung · 2019 · Pain
75. Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function – Implications for Potential Therapies
    Jörg Striessnig · 2021 · Frontiers in Synaptic Neuroscience
76. Visual snow syndrome, the spectrum of perceptual disorders, and migraine as a common risk factor: A narrative review
    Antonia Nicole Klein, Christoph Josef Schankin · 2021 · Headache The Journal of Head and Face Pain
77. The Amplification of Symptoms in the Medically Ill
    ARTHUR JOSEPH BARSKY, David Silbersweig · 2022 · Journal of General Internal Medicine
78. Neural signatures of auditory hypersensitivity following acoustic trauma
    Matthew McGill, Ariel Edward Hight, Yurika L. Watanabe, Aravindakshan Parthasarathy, Dongqin Cai, Kameron K. Clayton, Kenneth E. Hancock, Anne E. Takesian, Sharon G. Kujawa, Daniel B. Polley · 2022 · eLife
79. Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis
    Endang Mutiawati, Syahrul Syahrul, Marhami Fahriani, Jonny Karunia Fajar, Sukamto Salang Mamada, Helnida Anggun Maliga, Nur Samsu, Muhammad Ilmawan, Yeni Purnamasari, Anisa Asmiragani et al. · 2020 · F1000Research
80. Altered functional connectivity of the right caudate nucleus in chronic migraine: a resting-state fMRI study
    Ziyu Yuan, Wei Wang, Xueyan Zhang, Xiaoyan Bai, Hefei Tang, Yanliang Mei, Peng Zhang, Dong Qiu, Xue Zhang, Yaqing Zhang et al. · 2022 · The Journal of Headache and Pain
81. Multiple chemical sensitivity: It's time to catch up to the science
    John Molot, Margaret Sears, Hymie Anisman · 2023 · Neuroscience & Biobehavioral Reviews
82. Neuroimaging clues of migraine aura
    Nouchine K. Hadjikhani, Maurice Borges Vincent · 2019 · The Journal of Headache and Pain
83. Targeting CGRP and 5‐HT 1F Receptors for the Acute Therapy of Migraine: A Literature Review
    David Moreno‐Ajona, Calvin Chan, Maria Dolores Villar‐Martínez, Peter James Goadsby · 2019 · Headache The Journal of Head and Face Pain
84. Altered structural brain network topology in chronic migraine
    Danielle D. DeSouza, Yohannes Woubishet Woldeamanuel, Bharati M. Sanjanwala, Daniel A. Bissell, James H. Bishop, Addie M. Peretz, Robert Paul Cowan · 2019 · Brain Structure and Function
85. Monoclonal antibodies as a preventive therapy for migraine: A meta-analysis
    Yousef Al-Asa'd, Mohammad Z. Asha · 2020 · Clinical Neurology and Neurosurgery
86. Immunologic aspects of migraine: A review of literature
    Mehrnaz Salahi, Sina Parsa, Delaram Nourmohammadi, Zahra Razmkhah, Omid Salimi, Mohammadreza Rahmani, Saeid Zivary, Monireh Askarzadeh, Mohammad Amin Tapak, Ali Vaezi et al. · 2022 · Frontiers in Neurology
87. Exploring the Tryptophan Metabolic Pathways in Migraine-Related Mechanisms
    Tamás Körtési, Eleonóra Spekker, L. Vécsei · 2022 · Cells
88. Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications
    Kunming Zhou, Weifeng Luo, Tong Liu, Yong Ni, Zheng‐Hong Qin · 2022 · Toxins
89. Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
    Ja Bin Hong, Kristin Sophie Lange, Mira Pauline Fitzek, Lucas Hendrik Overeem, Paul Triller, Anke Siebert, Uwe Reuter, Bianca Raffaelli · 2023 · The Journal of Headache and Pain
90. Treating Chronic Migraine With Neuromodulation: The Role of Neurophysiological Abnormalities and Maladaptive Plasticity
    Alessandro Viganò, Massimiliano Toscano, Francesca Puledda, Vittorio Di Piero · 2019 · Frontiers in Pharmacology
91. Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis
    Peter James Goadsby, David W. Dodick, James Michael Martinez, Margaret B. Ferguson, Tina Marie Myers Oakes, Qi Zhang, Vladimir Skljarevski, Sheena K. Aurora · 2019 · Journal of Neurology Neurosurgery & Psychiatry
92. Exploring naturally occurring clinical subgroups of post-traumatic headache
    Tommy Lik Hang Chan, Yohannes Woubishet Woldeamanuel · 2020 · The Journal of Headache and Pain
93. Differential actions of indomethacin: clinical relevance in headache
    Oliver Summ, Anna P. Andreou, Simon Akerman, Philip R. Holland, Jan Hoffmann, Peter James Goadsby · 2020 · Pain
94. The childhood migraine syndrome
    Ishaq Abu‐Arafeh, Amy A. Gelfand · 2021 · Nature Reviews Neurology
95. Therapeutic Approaches to the Neurologic Manifestations of COVID-19
    Edith L. Graham, Igor Jerome Koralnik, Eric Michael Liotta · 2022 · Neurotherapeutics
96. Measuring interictal burden among people affected by migraine: a descriptive survey study
    Lena Hubig, Timothy R. Smith, Emma Williams, Lauren C. Powell, Karissa Johnston, Linda A. Harris, Gilbert J L'Italien, Vladimir Coric, Andrew J. Lloyd, Siu Hing Lo · 2022 · The Journal of Headache and Pain
97. Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
    Graham A. McLeod, Colin B. Josephson, Jordan D. T. Engbers, Lara Cooke, Samuel Wiebe · 2025 · Headache The Journal of Head and Face Pain
98. The Evidence for the Role of Nutraceuticals in the Management of Pediatric Migraine: a Review
    Serena Laura Orr · 2018 · Current Pain and Headache Reports
99. Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery
    Karissa E. Cottier, Emily A. Galloway, Elisa Calabrese, Margaret E. Tome, Erika Liktor‐Busa, John Kim, Thomas P. Davis, Todd W. Vanderah, Tally M. Largent‐Milnes · 2018 · eNeuro
100. Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
     Lena Ohlsson, Kristian Agmund Haanes, Erik Kronvall, Cen Xu, Josefin Snellman, Lars IH Edvinsson · 2019 · Cephalalgia